$NHPAP
National Healthcare Properties, Inc. Stock $nhpap

$nhpap Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000156103223000011 Filed on May 12, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$86.10M	$87.36M
YoY Change	2.72%	4.43%
Cost Of Revenue
YoY Change
Gross Profit	$32.54M	$33.47M
YoY Change	4.17%	9.53%
Gross Profit Margin	37.79%	38.32%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$20.18M
YoY Change		-1.19%
% of Gross Profit		60.28%
Operating Expenses	$84.99M	$85.53M
YoY Change	-5.32%	-10.86%
Operating Profit	$813.0K	$1.940M
YoY Change	-113.7%	-115.39%
Interest Expense	$18.70M	$15.79M
YoY Change	55.21%	34.18%
% of Operating Profit	2300.49%	813.66%
Other Income/Expense, Net	-$18.10M	-$15.96M
YoY Change	55.32%	48.37%
Pretax Income	-$17.29M	-$14.02M
YoY Change	-1.71%	-39.98%
Income Tax	$41.00K	$46.00K
% Of Pretax Income
Net Earnings	-$17.33M	-$14.07M
YoY Change	-1.72%	-39.88%
Net Earnings / Revenue	-20.13%	-16.1%
Basic Earnings Per Share	-$0.19	-$0.16
Diluted Earnings Per Share	-$0.19	-$0.16
COMMON SHARES
Basic Shares Outstanding	108.2M shares	106.6M shares
Diluted Shares Outstanding	109.7M shares	108.1M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$71.71M	$35.79M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.185B	$2.170B
YoY Change	0.32%	-1.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$1.226B	$1.196B
YoY Change	6.69%	3.61%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$1.082M	$1.066M
YoY Change	5.87%	5.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$952.9M	$968.0M
YoY Change
Total Liabilities & Shareholders Equity	$2.185B	$2.170B
YoY Change	0.32%	-1.09%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$17.33M	-$14.07M
YoY Change	-1.72%	-39.88%
Depreciation, Depletion And Amortization		$20.18M
YoY Change		-1.19%
Cash From Operating Activities		$4.989M
YoY Change		-15.18%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$29.08M
YoY Change		-444.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$8.898M
YoY Change		-229.61%
NET CHANGE
Cash From Operating Activities		$4.989M
Cash From Investing Activities		-$29.08M
Cash From Financing Activities		$8.898M
Net Change In Cash		-$15.19M
YoY Change		-303.48%
FREE CASH FLOW
Cash From Operating Activities		$4.989M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001561032
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10019
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-39153
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Healthcare Trust, Inc.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3888962
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	650 Fifth Ave.
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	30th Floor
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2023Q1	dei	City Area Code CityAreaCode	212
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	415-6500
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	108184213	shares
CY2023Q1	us-gaap	Land Land	208539000	usd
CY2022Q4	us-gaap	Land Land	206454000	usd
CY2023Q1	hct	Buildings Fixturesand Improvements BuildingsFixturesandImprovements	2111236000	usd
CY2022Q4	hct	Buildings Fixturesand Improvements BuildingsFixturesandImprovements	2089133000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	295979000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	292034000	usd
CY2023Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2615754000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2587621000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	628541000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	609324000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1987213000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1978297000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35794000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53654000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	25554000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	22884000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	30419000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	40647000	usd
CY2023Q1	us-gaap	Deferred Rent Receivables Net Noncurrent DeferredRentReceivablesNetNoncurrent	25473000	usd
CY2022Q4	us-gaap	Deferred Rent Receivables Net Noncurrent DeferredRentReceivablesNetNoncurrent	25276000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7789000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7814000	usd
CY2023Q1	us-gaap	Due From Related Parties DueFromRelatedParties	12000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	41200000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	34554000	usd
CY2023Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	16614000	usd
CY2022Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	17223000	usd
CY2023Q1	us-gaap	Assets Assets	2170056000	usd
CY2022Q4	us-gaap	Assets Assets	2180349000	usd
CY2023Q1	us-gaap	Secured Debt SecuredDebt	578772000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	578700000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	549205000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	530297000	usd
CY2023Q1	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	9060000	usd
CY2022Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	9407000	usd
CY2023Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	123000	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	47000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	40574000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	45247000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	8075000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	8087000	usd
CY2023Q1	us-gaap	Deferred Rent Credit DeferredRentCredit	6449000	usd
CY2022Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	5925000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3496000	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3496000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1195631000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1181159000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	106668245	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	106668245	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	105080531	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	105080531	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	1066000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1051000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2439662000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2417059000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	29479000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	36910000	usd
CY2023Q1	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	1502299000	usd
CY2022Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	1462457000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	967984000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	992639000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	6441000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	6551000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	974425000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	999190000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2170056000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2180349000	usd
CY2023Q1	us-gaap	Revenues Revenues	87355000	usd
CY2022Q1	us-gaap	Revenues Revenues	83650000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	53883000	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	53090000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2022Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	10644000	usd
CY2023Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	6387000	usd
CY2022Q1	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	6318000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	63000	usd
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	579000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5021000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4899000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20176000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20420000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	85530000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	95950000	usd
CY2023Q1	hct	Operating Income Loss Before Gain Losson Saleof Real Estate Investments OperatingIncomeLossBeforeGainLossonSaleofRealEstateInvestments	1825000	usd
CY2022Q1	hct	Operating Income Loss Before Gain Losson Saleof Real Estate Investments OperatingIncomeLossBeforeGainLossonSaleofRealEstateInvestments	-12300000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	115000	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-303000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1940000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12603000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	15785000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	11764000	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	5000	usd
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	12000	usd
CY2023Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-182000	usd
CY2022Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	994000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15962000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10758000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14022000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23361000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-14068000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-23400000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-9000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-49000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3450000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3450000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17509000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26801000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-7431000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	26266000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24940000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-535000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108087025	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108087025	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108013529	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108013529	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	999190000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-2000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	230000	usd
CY2023Q1	hct	Common Stock Stock Dividends Per Share Declared CommonStockStockDividendsPerShareDeclared	0.21
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	0	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	46000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-14068000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-7431000	usd
CY2023Q1	hct	Adjustmentsto Additional Paidin Capital Rebalancing Of Ownership Percentage AdjustmentstoAdditionalPaidinCapitalRebalancingOfOwnershipPercentage	0	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	974425000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1040400000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-54000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	332000	usd
CY2022Q1	hct	Common Stock Stock Dividends Per Share Declared CommonStockStockDividendsPerShareDeclared	0.21
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	0	usd
CY2022Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	46000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-23400000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	26266000	usd
CY2022Q1	hct	Adjustmentsto Additional Paidin Capital Rebalancing Of Ownership Percentage AdjustmentstoAdditionalPaidinCapitalRebalancingOfOwnershipPercentage	0	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1040094000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-14068000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-23400000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20176000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20420000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1382000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1181000	usd
CY2023Q1	hct	Amortization Accretion Of Terminated Swap Payment AmortizationAccretionOfTerminatedSwapPayment	-257000	usd
CY2022Q1	hct	Amortization Accretion Of Terminated Swap Payment AmortizationAccretionOfTerminatedSwapPayment	211000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	23000	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	107000	usd
CY2023Q1	hct	Accretion Of Below Market Lease Liabilities And Amortization Of Above Market Lease Assets Net AccretionOfBelowMarketLeaseLiabilitiesAndAmortizationOfAboveMarketLeaseAssetsNet	-211000	usd
CY2022Q1	hct	Accretion Of Below Market Lease Liabilities And Amortization Of Above Market Lease Assets Net AccretionOfBelowMarketLeaseLiabilitiesAndAmortizationOfAboveMarketLeaseAssetsNet	-122000	usd
CY2023Q1	hct	Operating Lease Net Investmentin Lease Credit Loss Expense Reversal OperatingLeaseNetInvestmentinLeaseCreditLossExpenseReversal	265000	usd
CY2022Q1	hct	Operating Lease Net Investmentin Lease Credit Loss Expense Reversal OperatingLeaseNetInvestmentinLeaseCreditLossExpenseReversal	426000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	230000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	332000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	115000	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-303000	usd
CY2023Q1	hct	Derivative Instruments Not Designated As Hedging Instruments Cash Received DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsCashReceived	926000	usd
CY2022Q1	hct	Derivative Instruments Not Designated As Hedging Instruments Cash Received DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsCashReceived	0	usd
CY2023Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-182000	usd
CY2022Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	994000	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	10644000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	217000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	394000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-538000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-981000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-4389000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2045000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	524000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1768000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4989000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5882000	usd
CY2023Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	25443000	usd
CY2022Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	0	usd
CY2023Q1	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	3634000	usd
CY2022Q1	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	3311000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	0	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Real Estate Heldforinvestment ProceedsFromSaleOfRealEstateHeldforinvestment	11759000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29077000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	8448000	usd
CY2023Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1442000	usd
CY2022Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	20000000	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	283000	usd
CY2022Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	3374000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Derivative Instrument Financing Activities PaymentsForProceedsFromDerivativeInstrumentFinancingActivities	-1946000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Derivative Instrument Financing Activities PaymentsForProceedsFromDerivativeInstrumentFinancingActivities	39000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	44000	usd
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	40000	usd
CY2023Q1	hct	Payments For Escrow Deposit PaymentsForEscrowDeposit	7783000	usd
CY2022Q1	hct	Payments For Escrow Deposit PaymentsForEscrowDeposit	0	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2000	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	6000	usd
CY2023Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	46000	usd
CY2022Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	46000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8898000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-6865000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-15190000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7465000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	76538000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	85382000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	61348000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	92847000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35794000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66424000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	25554000	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	26423000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	61348000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	92847000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	12876000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	10269000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	140000	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	372000	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	22335000	usd
CY2022Q1	us-gaap	Stock Issued1 StockIssued1	21104000	usd
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	207	property
CY2023Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	34	state
CY2023Q1	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	9200000	sqft
CY2023Q1	hct	Numberof Senior Housing Communities NumberofSeniorHousingCommunities	50	property
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q1	hct	Number Of Independent Contractors NumberOfIndependentContractors	4	contractor
CY2023Q1	hct	Numberof Senior Housing Communities NumberofSeniorHousingCommunities	50	property
	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	14000000	shares
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Management makes significant estimates regarding revenue recognition, purchase price allocations to record investments in real estate, impairments, fair value measurements and income taxes, as applicable.</span></div>
CY2022	hct	Proceeds From Government Assistance Cares Act ProceedsFromGovernmentAssistanceCARESAct	4500000	usd
CY2021	hct	Proceeds From Government Assistance Cares Act ProceedsFromGovernmentAssistanceCARESAct	5100000	usd
CY2020	hct	Proceeds From Government Assistance Cares Act ProceedsFromGovernmentAssistanceCARESAct	3600000	usd
CY2022Q1	hct	Proceeds From Government Assistance Cares Act ProceedsFromGovernmentAssistanceCARESAct	0	usd
CY2023Q1	hct	Lease Remaining Lease Term LeaseRemainingLeaseTerm	P4Y10M24D
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	0	usd
CY2023Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	0	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	80916000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	103347000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	92567000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	84648000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	66412000	usd
CY2023Q1	hct	Lessor Operating Lease Paymenttobe Receivedafter Year Four LessorOperatingLeasePaymenttobeReceivedafterYearFour	229080000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	656970000	usd
CY2023Q1	hct	Operating Lease Net Investmentin Lease Credit Loss Expense Reversal OperatingLeaseNetInvestmentinLeaseCreditLossExpenseReversal	300000	usd
CY2022Q1	hct	Operating Lease Net Investmentin Lease Credit Loss Expense Reversal OperatingLeaseNetInvestmentinLeaseCreditLossExpenseReversal	400000	usd
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q1	hct	Numberof Senior Housing Communities NumberofSeniorHousingCommunities	50	property
CY2020	hct	Number Of Intercompany Leases Modified NumberOfIntercompanyLeasesModified	25	lease
CY2023Q1	hct	Deferred Tax Asset Valuation Allowance Percentage DeferredTaxAssetValuationAllowancePercentage	1
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7600000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6900000	usd
CY2023Q1	hct	Proceeds From Government Assistance Cares Act ProceedsFromGovernmentAssistanceCARESAct	0	usd
CY2022Q1	hct	Proceeds From Government Assistance Cares Act ProceedsFromGovernmentAssistanceCARESAct	0	usd
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	119	encumberedproperty
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	207	property
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	549205000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	530297000	usd
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0662
CY2023Q1	hct	Disposal Group Including Discontinued Operation Number Of Properties Disposed DisposalGroupIncludingDiscontinuedOperationNumberOfPropertiesDisposed	0	property
CY2023Q1	hct	Real Estate Investment At Cost Relatingto Notes Payable RealEstateInvestmentAtCostRelatingtoNotesPayable	900000000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0594
CY2023Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2600000000	usd
CY2023Q1	hct	Real Estate Investment At Cost Relatingto Notes Payable RealEstateInvestmentAtCostRelatingtoNotesPayable	900000000	usd
CY2023Q1	hct	Debt Instrument Covenants Minimum Cash Cash Equivalentsand Borrowing Capacity DebtInstrumentCovenantsMinimumCashCashEquivalentsandBorrowingCapacity	50000000	usd
CY2023Q1	hct	Debt Instrument Covenants Distribution In Excess Of Modified Funds From Operations Percent DebtInstrumentCovenantsDistributionInExcessOfModifiedFundsFromOperationsPercent	0.95
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	5183000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	206947000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	19039000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	714133000	usd
CY2023Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	922000	usd
CY2023Q1	hct	Long Term Debt Maturityafter Year Four LongTermDebtMaturityafterYearFour	189278000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1135502000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Derivative Instrument Financing Activities PaymentsForProceedsFromDerivativeInstrumentFinancingActivities	-1900000	usd
CY2023Q1	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2023Q1	us-gaap	Derivative Assets DerivativeAssets	30419000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	15785000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	11764000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Derivative Instrument Financing Activities PaymentsForProceedsFromDerivativeInstrumentFinancingActivities	-1900000	usd
CY2023Q1	hct	Number Of Interest Rate Derivatives Not Yet In Effect NumberOfInterestRateDerivativesNotYetInEffect	3	derivative
CY2023Q1	hct	Derivative Notional Amount Not Yet In Effect DerivativeNotionalAmountNotYetInEffect	52600000	usd
CY2023Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-200000	usd
CY2022Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	1000000	usd
CY2023Q1	hct	Derivative Instruments Not Designated As Hedging Instruments Cash Received DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsCashReceived	900000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	30419000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0	usd
CY2023Q1	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	usd
CY2023Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	30419000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	40647000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0	usd
CY2022Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	40647000	usd
CY2022Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	usd
CY2022Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	40647000	usd
CY2023Q1	us-gaap	Shares Outstanding SharesOutstanding	106668245	shares
CY2022Q4	us-gaap	Shares Outstanding SharesOutstanding	105080531	shares
	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	14000000	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0	shares
CY2023Q1	hct	Stock Repurchase Program Share Price Percentage Of Estimated Per Share Nav StockRepurchaseProgramSharePricePercentageOfEstimatedPerShareNAV	1
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	4896620	shares
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	20.60
CY2023Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2023Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	0
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	4896620	shares
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	20.60
CY2023Q1	hct	Drip Periodof Noticeto Alter Agreement DRIPPeriodofNoticetoAlterAgreement	P10D
CY2023Q1	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	0	shares
CY2022	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	0	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2020Q3	hct	Preferred Stock Additional Shares Authorized PreferredStockAdditionalSharesAuthorized	600000	shares
CY2018Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.85
CY2020Q4	us-gaap	Stock Dividends Shares StockDividendsShares	0.013492	shares
CY2021Q1	us-gaap	Stock Dividends Shares StockDividendsShares	0.013492	shares
CY2021Q2	us-gaap	Stock Dividends Shares StockDividendsShares	0.014655	shares
CY2021Q3	us-gaap	Stock Dividends Shares StockDividendsShares	0.014655	shares
CY2021Q4	us-gaap	Stock Dividends Shares StockDividendsShares	0.014655	shares
CY2022Q1	us-gaap	Stock Dividends Shares StockDividendsShares	0.014655	shares
CY2022Q2	us-gaap	Stock Dividends Shares StockDividendsShares	0.014167	shares
CY2022Q3	us-gaap	Stock Dividends Shares StockDividendsShares	0.014167	shares
CY2022Q4	us-gaap	Stock Dividends Shares StockDividendsShares	0.014167	shares
CY2023Q1	us-gaap	Stock Dividends Shares StockDividendsShares	0.014167	shares
CY2023Q1	us-gaap	Limited Partners Capital Account Units Outstanding LimitedPartnersCapitalAccountUnitsOutstanding	90	shares
CY2022Q4	us-gaap	Limited Partners Capital Account Units Outstanding LimitedPartnersCapitalAccountUnitsOutstanding	90	shares
CY2017Q1	hct	Related Party Agreement Termof Agreement Renewal Period RelatedPartyAgreementTermofAgreementRenewalPeriod	P10Y
CY2017Q1	hct	Related Party Agreement Termof Agreement Renewal Period RelatedPartyAgreementTermofAgreementRenewalPeriod	P10Y
CY2017Q1	hct	Related Party Transaction Voting Percentage Requiredto Alter Agreement RelatedPartyTransactionVotingPercentageRequiredtoAlterAgreement	0.67
CY2017Q1	hct	Related Party Transaction Periodof Noticeto Alter Agreement RelatedPartyTransactionPeriodofNoticetoAlterAgreement	P45D
CY2023Q1	hct	Share Price Equity Instruments Netof Selling Commissionsand Dealer Fees SharePriceEquityInstrumentsNetofSellingCommissionsandDealerFees	22.50
CY2023Q1	us-gaap	Minority Interest In Operating Partnerships MinorityInterestInOperatingPartnerships	6045000	usd
CY2022Q4	us-gaap	Minority Interest In Operating Partnerships MinorityInterestInOperatingPartnerships	6162000	usd
CY2023Q1	hct	Noncontrolling Interests In Property Owning Subsidiaries NoncontrollingInterestsInPropertyOwningSubsidiaries	396000	usd
CY2022Q4	hct	Noncontrolling Interests In Property Owning Subsidiaries NoncontrollingInterestsInPropertyOwningSubsidiaries	389000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	6441000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	6551000	usd
CY2022Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	46000	usd
CY2023Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	46000	usd
CY2023Q1	us-gaap	Limited Partners Capital Account Units Outstanding LimitedPartnersCapitalAccountUnitsOutstanding	90	shares
CY2022Q4	us-gaap	Limited Partners Capital Account Units Outstanding LimitedPartnersCapitalAccountUnitsOutstanding	90	shares
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2022Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17509000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26801000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108087025	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108087025	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	108013529	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	108013529	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	994975	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1068456	shares
CY2023Q1	hct	Common Share Equivalents Shares Outstanding CommonShareEquivalentsSharesOutstanding	359250	shares
CY2022Q1	hct	Common Share Equivalents Shares Outstanding CommonShareEquivalentsSharesOutstanding	359250	shares
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q1	us-gaap	Revenues Revenues	87355000	usd
CY2022Q1	us-gaap	Revenues Revenues	83650000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	53883000	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	53090000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	33472000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	30560000	usd
CY2023Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2022Q1	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	10644000	usd
CY2023Q1	us-gaap	Affiliate Costs AffiliateCosts	6387000	usd
CY2022Q1	us-gaap	Affiliate Costs AffiliateCosts	6318000	usd
CY2023Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	63000	usd
CY2022Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	579000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5021000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4899000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20176000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	20420000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	15785000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	11764000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	5000	usd
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	12000	usd
CY2023Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	115000	usd
CY2022Q1	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-303000	usd
CY2023Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-182000	usd
CY2022Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	994000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-9000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-49000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3450000	usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3450000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17509000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26801000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1987213000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1978297000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35794000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	53654000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	25554000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	22884000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	30419000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	40647000	usd
CY2023Q1	us-gaap	Deferred Rent Receivables Net Noncurrent DeferredRentReceivablesNetNoncurrent	25473000	usd
CY2022Q4	us-gaap	Deferred Rent Receivables Net Noncurrent DeferredRentReceivablesNetNoncurrent	25276000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7789000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7814000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	41200000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	34554000	usd
CY2023Q1	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	16614000	usd
CY2022Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	17223000	usd
CY2023Q1	us-gaap	Assets Assets	2170056000	usd
CY2022Q4	us-gaap	Assets Assets	2180349000	usd
CY2023Q1	hct	Lessee Operating Lease Number Of Contracts LesseeOperatingLeaseNumberOfContracts	7	lease
CY2023Q1	hct	Lessee Finance Lease Number Of Contracts LesseeFinanceLeaseNumberOfContracts	6	lease
CY2023Q1	hct	Lessee Operating Lease Number Of Contracts LesseeOperatingLeaseNumberOfContracts	7	lease
CY2023Q1	hct	Lessee Operating Lease Renewal Term Excluded LesseeOperatingLeaseRenewalTermExcluded	P1Y6M
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7800000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	8100000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P34Y
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0737
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	200000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	200000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	200000	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	200000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	486000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	66000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	632000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	90000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	588000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	93000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	599000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	95000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	617000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	97000	usd
CY2023Q1	hct	Lessee Operating Lease Liabilitytobe Paid Dueafter Year Four LesseeOperatingLeaseLiabilitytobePaidDueafterYearFour	21942000	usd
CY2023Q1	hct	Finance Lease Liabilitytobe Paid Dueafter Year Four FinanceLeaseLiabilitytobePaidDueafterYearFour	7215000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	24864000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	7656000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	16789000	usd
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2820000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	8075000	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	4836000	usd

Files In Submission

Name	View Source	Status
hct-20230331_cal.xml	Edgar Link	unprocessable
hct-20230331_lab.xml	Edgar Link	unprocessable
0001561032-23-000011-index-headers.html	Edgar Link	pending
0001561032-23-000011-index.html	Edgar Link	pending
0001561032-23-000011.txt	Edgar Link	pending
0001561032-23-000011-xbrl.zip	Edgar Link	pending
ex311hti3312023.htm	Edgar Link	pending
ex312hti3312023.htm	Edgar Link	pending
ex32hti3312023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hct-20230331.htm	Edgar Link	pending
hct-20230331.xsd	Edgar Link	pending
hct-20230331_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
hct-20230331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
hct-20230331_pre.xml	Edgar Link	unprocessable
hct-20230331_htm.xml	Edgar Link	completed
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHPAP
National Healthcare Properties, Inc. Stock $nhpap

2023 Q2 Form 10-Q Financial Statement

#000156103223000011 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHPAP National Healthcare Properties, Inc. Stock $nhpap

2023 Q2 Form 10-Q Financial Statement

#000156103223000011 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHPAP
National Healthcare Properties, Inc. Stock $nhpap